doxorubicin

the name doxorubicin is a constructed scientific term from the mid-20th century, designed to describe its chemical relationship to the similar compound daunorubicin. the first element, 'doxo-', is a condensed and altered form from 'deoxydaunorubicin', hinting at a structural modification involving the loss of an oxygen atom. the core component '-rubi-' directly references the latin root for 'red', a vivid descriptor for the characteristic red hue of this anthracycline drug produced by the streptomyces bacterium. the concluding '-cin' is a standard microbiological suffix denoting an antibiotic agent, solidifying its classification within pharmacology. thus, the name literally translates to a 'red antibiotic', with the 'doxo-' prefix specifying its unique chemical variant status within this colored family of chemotherapeutic agents.

Structure: doxo (related to red) + rubi (red) + cin (antibiotic suffix) doxo: from greek 'doxa', meaning 'glory' or 'opinion', but here used in a scientific context as a truncated form of 'deoxydaunorubicin', with 'dox-' likely influenced by the trade name 'adriamycin' and the chemical structure related to the red pigment. rubi: from latin 'rubeus', meaning 'red', referring to the red color of the compound produced by the bacterium. cin: a common suffix in antibiotic names (e.g., streptomycin, vancomycin), derived from the scientific latin suffix '-cinus', indicating a substance derived from a microorganism.